Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ASIC3 | Q9UHC3 | 2/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.52 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.52 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.52 |
| ▸ | ACACB | O00763 | 1/20 | 0.46 |
| ▸ | CYP2A6 | P11509 | 6/20 | 0.46 |
| ▸ | CA1 | P00915 | 2/20 | 0.46 |
| ▸ | CA2 | P00918 | 2/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | CA7 | P43166 | 1/20 | 0.46 |
| ▸ | CA9 | Q16790 | 1/20 | 0.46 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.44 |
| ▸ | APP | P05067 | 1/20 | 0.43 |
| ▸ | CES2 | O00748 | 1/20 | 0.41 |
| ▸ | CES1 | P23141 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10705668 | 0.93 | ASIC3 (0.63) | ASIC3CYP1A2CYP1A1CYP1B1ACACB | |
| SCHEMBL30447338 | 0.93 | ASIC3 (0.63) | ASIC3CYP1A2CYP1A1CYP1B1ACACB | |
| SCHEMBL5572006 | 0.92 | ASIC3 (0.52) | ASIC3CYP1A2CYP1A1CYP1B1ACACB | |
| SCHEMBL5573818 | 0.92 | ASIC3 (0.52) | ASIC3CYP1A2CYP1A1CYP1B1ACACB | |
| SCHEMBL7702432 | 0.90 | CYP1A2 (0.48) | ASIC3CYP1A2CYP1A1CYP1B1ACACB | |
| SCHEMBL15185720 | 0.87 | MEN1 (0.49) | ASIC3CYP1A2CYP1A1CYP1B1ACACB | |
| SCHEMBL15014341 | 0.87 | CYP2A6 (0.58) | ASIC3CYP1A2CYP1A1CYP1B1ACACB | |
| SCHEMBL14849821 | 0.87 | CYP2A6 (0.58) | ASIC3CYP1A2CYP1A1CYP1B1ACACB | |
| SCHEMBL23883181 | 0.85 | CYP1A2 (0.50) | ASIC3CYP1A2CYP1A1CYP1B1ACACB | |
| SCHEMBL8628482 | 0.85 | ASIC3 (0.61) | ASIC3CYP1A2CYP1A1CYP1B1ACACB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023157909-A1 | METHOD FOR PRODUCING DIARYLACETYLENE DERIVATIVE | 関東電化工業株式会社 | 2023-08-24 | — | — | WO | disclosed |
| EP-2757086-A1 | Hydrocarbon-based fused ring compound and organic light emitting device using the same | Heesung Material Ltd. (KR) | 2014-07-23 | — | — | EP | disclosed |
| CN-103922883-A | Hydrocarbon-based fused ring compound and organic light emitting device using the same | HEESUNG MAT LTD | 2014-07-16 | — | — | CN | disclosed |
| EP-1654207-B1 | BIS(2-ACENYL)ACETYLENE SEMICONDUCTORS | 3M INNOVATIVE PROPERTIES CO (US) | 2007-08-22 | — | — | EP | disclosed |
| US-7109519-B2 | Bis(2-acenyl)acetylene semiconductors | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2006-09-19 | — | — | US | disclosed |
| EP-1654207-A1 | BIS(2-ACENYL)ACETYLENE SEMICONDUCTORS | 3M Innovative Properties Company (US) | 2006-05-10 | — | — | EP | disclosed |
| WO-2005014511-A1 | BIS(2-ACENYL)ACETYLENE SEMICONDUCTORS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2005-02-17 | — | — | WO | disclosed |
| US-20050012090-A1 | Bis(2-acenyl)acetylene semiconductors | 3M INNOVATIVE PROPERTIES COMPANY | 2005-01-20 | — | — | US | disclosed |
| US-5374701-A | Crosslinkable polymers of high strength free of structural defects | HAY ALLAN S (CA) | 1994-12-20 | — | — | US | disclosed |
| US-5233046-A | DIARYLACETYLENES, ENAMINES AND ACETYLENIC POLYMERS AND THEIR PRODUCTION | HAY ALLAN S (CA) | 1993-08-03 | — | — | US | disclosed |
| WO-1993009079-A1 | DIARYLACETYLENES, ENAMINES AND ACETYLENIC POLYMERS AND THEIR PRODUCTION | HAY ALAN S (CA) | 1993-05-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050012090-A1 | Bis(2-acenyl)acetylene semiconductors | LAMP2, ACAT1, SAT1 | ASIC3 1274/4885CYP1A2 2762/4885CYP1A1 2842/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.